Ameriprise’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,944
Closed -$251K 4039
2024
Q4
$251K Buy
+9,944
New +$270K ﹤0.01% 3784
2018
Q2
Sell
-512,961
Closed -$17.9M 3645
2018
Q1
$17.9M Buy
512,961
+479,589
+1,437% +$18.6M 0.01% 1203
2017
Q4
$1.42M Buy
33,372
+3,945
+13% +$169K ﹤0.01% 2834
2017
Q3
$1.26M Buy
29,427
+3,975
+16% +$149K ﹤0.01% 2859
2017
Q2
$943K Buy
+25,452
New +$1.13M ﹤0.01% 2970
2016
Q1
Sell
-16,185
Closed -$3.81M 3766
2015
Q4
$3.81M Buy
16,185
+1,538
+11% +$335K ﹤0.01% 2219
2015
Q3
$2.32M Sell
14,647
-5,837
-28% -$1.65M ﹤0.01% 2535
2015
Q2
$7.75M Buy
20,484
+4,213
+26% +$1.67M ﹤0.01% 1803
2015
Q1
$6.8M Buy
16,271
+10,581
+186% +$3.79M ﹤0.01% 1889
2014
Q4
$1.56M Buy
5,690
+2,576
+83% +$640K ﹤0.01% 2664
2014
Q3
$605K Sell
3,114
-761
-20% -$166K ﹤0.01% 2982
2014
Q2
$948K Sell
3,875
-19,844
-84% -$4.48M ﹤0.01% 2793
2014
Q1
$6.29M Sell
23,719
-14,543
-38% -$5.57M ﹤0.01% 1867
2013
Q4
$13.9M Buy
38,262
+11,938
+45% +$4.6M 0.01% 1262
2013
Q3
$14M Buy
26,324
+21,108
+405% +$7.24M 0.01% 1236
2013
Q2
$1.22M Buy
+5,216
New +$1.03M ﹤0.01% 2546

Other funds holding CLDX